Readers Rate Core Labs

Premium

People love to complain. Researchers complain about their core labs and core lab workers complain about their users. But how unhappy is everyone, really? Respondents to Genome Technology's fourth core lab survey say they are generally happy with their core labs, consistently awarding them a "good" rating for most metrics. Respondents were particularly pleased with the accuracy of results and the quality of support staff at their cores. Correspondingly, core lab workers said they valued results accuracy and support staff quality in serving their customers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.